This efficacy and safety trial will examine the effects and safety of propranolol
administered to adult patients with severe burn injury. The investigators hypothesize that
propranolol will provide significant benefit to adults following severe burn injury at doses
that are safe and do not increase risk of adverse infectious and non-infectious outcomes.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Collaborators:
American Burn Association United States Department of Defense